IGF1 and neoplasm: In breast cancer, systematic analysis by flow cytometry cell sorting of single-cell suspensions of tumor cells, non-immune stromal cells, and macrophages identified TAMs and CAFs as the main sources of IGF1/IGF2 ligands in the breast tumor microenvironment [79].